Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions.

MLA

Ormiston, John A., et al. “Final 5-Year Results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion Clinical Trials of the TAXUS Liberté Paclitaxel-Eluting Stent in de-Novo Coronary Artery Lesions.” Coronary Artery Disease, vol. 24, no. 1, Jan. 2013, pp. 61–68. EBSCOhost, https://doi.org/10.1097/MCA.0b013e32835b3932.

APA

Ormiston, J. A., Charles, O., Mann, T., Hall, J. J., McGarry, T., Cannon, L. A., Webster, M. W. I., Mishkel, G. J., Underwood, P. L., & Dawkins, K. D. (2013). Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions. Coronary Artery Disease, 24(1), 61–68. https://doi.org/10.1097/MCA.0b013e32835b3932

Chicago

Ormiston, John A, O’Shaughnessy Charles, Tift Mann, Jack J Hall, Thomas McGarry, Louis A Cannon, Mark W I Webster, Gregory J Mishkel, Paul L Underwood, and Keith D Dawkins. 2013. “Final 5-Year Results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion Clinical Trials of the TAXUS Liberté Paclitaxel-Eluting Stent in de-Novo Coronary Artery Lesions.” Coronary Artery Disease 24 (1): 61–68. doi:10.1097/MCA.0b013e32835b3932.